Adenoviral preterminal protein stabilizes mini-adenoviral genomes in vitro and in vivo
- 1 December 1997
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 15 (13), 1383-1387
- https://doi.org/10.1038/nbt1297-1383
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivoGene Therapy, 1997
- A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signalProceedings of the National Academy of Sciences, 1996
- 293 Cell Lines That Inducibly Express High Levels of Adenovirus Type 5 Precursor Terminal ProteinVirology, 1996
- Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cellsHuman Molecular Genetics, 1996
- A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.Proceedings of the National Academy of Sciences, 1996
- Current status of CF gene therapyTrends in Genetics, 1996
- Adenovirus DNA ReplicationPublished by Springer Nature ,1995
- Association of nuclear matrix antigens with exon-containing splicing complexes.The Journal of cell biology, 1994
- Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.Proceedings of the National Academy of Sciences, 1994
- Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffoldCell, 1984